European Market Access

Once their French market access strategy has been defined, or in parallel with its development, most of our clients need to establish their position in other key European markets.

This expansion cannot be approached on a country-by-country basis in isolation. In most European healthcare systems, the price established in one country serves as a direct or indirect reference for negotiations in neighbouring markets. This is precisely why defining a pricing corridor is essential: it enables manufacturers to anticipate international reference pricing dynamics, plan an effective launch sequence and protect the product’s value across European markets.

Across Europe, we do not act as regulatory experts for every national healthcare system. Instead, we work in coordination with specialist consultants for each category of healthcare product to develop a regional market access strategy and pricing corridor.

Our added value lies in our role as a strategic coordinator, ensuring consistency across the European launch sequence and alignment between national market access strategies.

Are you planning to expand your market access strategy across Europe? Contact us to develop your launch sequence and pricing corridor together.

Frequently Asked Questions

Not entirely. Each national healthcare system has its own procedures and requirements, but because prices are referenced across countries, an effective strategy must be developed at the European level, anticipating the order and timing of product launches across the region.

No. We coordinate the regional market access strategy and pricing corridor, drawing on a network of local consultants specialising in individual countries and healthcare product categories to manage implementation within each national healthcare system.

However, on a case-by-case basis, we also provide direct support in countries with a French-speaking component to their healthcare systems, such as Belgium, Luxembourg and Switzerland.

This depends on the product, its demonstrated incremental clinical value and the implications of international reference pricing. Identifying the optimal launch sequence is precisely the purpose of the strategic planning we undertake with you when defining the pricing corridor.